{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-017112","form_type":"8-K","ticker":"AQST","cik":"0001398733","company_name":"Aquestive Therapeutics, Inc.","filed_at":"2024-04-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.237957+00:00","generated_at":"2026-06-03T13:38:20.420668+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Aquestive Therapeutics raises $77.5M in public offering; over-allotment exercised","bullets":["Underwriters exercised over-allotment for 559,801 shares at $4.50 on April 22, 2024.","Total gross proceeds approximate $77.5M from 17.2M shares issued.","Offering co-managed by Leerink Partners, Piper Sandler; Oppenheimer as lead manager.","Over-allotment exercised 30 days after initial closing of March 22, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-017112","json":"https://secwatch.observer/filing/0001628280-24-017112.json","markdown":"https://secwatch.observer/filing/0001628280-24-017112.md","text":"https://secwatch.observer/filing/0001628280-24-017112.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1398733/000162828024017112/0001628280-24-017112-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1398733/000162828024017112/aqst-20240422.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T13:38:20.420668+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}